Skip to main content
Fig. 6 | BMC Research Notes

Fig. 6

From: The effect of glatiramer acetate, IFNβ-1a, fingolimod, and dimethyl fumarate on the expression of T-bet, IFN-γ, and MEG3 in PBMC of RRMS patients

Fig. 6

The diagnostic values of T-bet, MEG3, and IFN-γ in RRMS patients: T-bet as a Promising Diagnostic Marker for Treatment-Naïve RRMS Patients. T-bet exhibits strong diagnostic potential with an AUC of 0.81 (P-value = 0.03), surpassing IFN-γ and MEG3. The optimal cutoff point (> 0.6135, 95% CI = 0.5636 to 1.000) offers a sensitivity of 80.00% and specificity of 90.00%

Back to article page

BMC Research Notes

ISSN: 1756-0500

Contact us